Journal article
Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial.
- Abstract:
-
The development of effective vaccines against difficult disease targets will require the identification of new subunit vaccination strategies that can induce and maintain effective immune responses in humans. Here we report on a phase 1a clinical trial using the AMA1 antigen from the blood-stage Plasmodium falciparum malaria parasite delivered either as recombinant protein formulated with Alhydrogel adjuvant with and without CPG 7909, or using recombinant vectored vaccines--chimpanzee adenovi...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Publisher:
- Nature Publishing Group
- Journal:
- Molecular therapy : the journal of the American Society of Gene Therapy
- Volume:
- 22
- Issue:
- 12
- Pages:
- 2142-2154
- Publication date:
- 2014-12-01
- DOI:
- EISSN:
-
1525-0024
- ISSN:
-
1525-0016
- Source identifiers:
-
482202
Item Description
- Language:
- English
- Pubs id:
-
pubs:482202
- UUID:
-
uuid:9b8ab0ec-376a-4055-afc2-7d3349e9401f
- Local pid:
- pubs:482202
- Deposit date:
- 2014-09-15
Terms of use
- Copyright date:
- 2014
If you are the owner of this record, you can report an update to it here: Report update to this record